Ubiquitin-conjugation targets numerous cellular regulators for proteasome-mediated degradation. Thus, the identi®cation of ubiquitin ligases and their physiological substrates is crucially important, especially for those cases in which aberrant levels of regulatory proteins (e.g., b-catenin, p27) result from a deregulated ubiquitination pathway. In yeast, the proteolysis of several G1 regulators is controlled by ubiquitin ligases (or SCFs) formed by three subunits: Skp1, Cul A (Cdc53), and one of many F-box proteins. Speci®c 
Introduction
Proteolysis of cyclins, Cdk-inhibitors (Ckis) and other G1 regulatory proteins is controlled in yeast by ubiquitin ligases formed by three protein subunits: Cul A (also called Cdc53), Skp1 and one of many Fbox proteins (reviewed in Pagano, 1997) . Because these ligases are similar protein modules composed of Skp1, Cul A, and an F-box protein, they have been named SCFs. The F-box proteins (Fbps) are so-called because they contain an F-box motif (®rst identi®ed in Cyclin F) necessary for their interaction with Skp1 (Bai et al., 1996) . In addition to the F-box, Fbps that are subunits of ubiquitin ligases contain other protein-protein interaction domains, such as WD-40 domains or leucine-rich repeats, that are involved in the recognition of speci®c substrates. The three SCFs identi®ed so far in S. cerevisiñ contain one of three Fbps (Cdc4, Grr1 or Met30) which target dierent substrates for ubiquitination. SCF Cdc4 recruits as substrates the Sic1 and Far1 Cdk-inhibitors, the replication factor Cdc6, and the transcriptional activator Gcn4. SCF Grr1 recruits the G1 cyclins Cln1 and Cln2, and SCF Mat30 recruits the G1 cyclin Cln3 and the Cdk-inhibitory kinase Swe1 (see Pagano, 1997 for a recent review). As in yeast, degradation of human regulatory proteins (cyclins, Ckis, E2F, b-catenin, IkBa, etc.) is controlled by the ubiquitin-pathway (reviewed in Pagano, 1997 ). Yet, the speci®c ubiquitin ligases involved in the degradation of G1 regulatory proteins have not been identi®ed. So far, one human SCF (SCF Skp2 ) has been identi®ed whose component are Skp1, Cul1 and an Fbp named Skp2 (Lisztwan et al., 1998; Lyapina et al., 1998; Michel and Xiong, 1998; Yu et al., 1998) . Anti-sense experiments suggest that cyclin D1 and the Cki p21 are substrates of SCF Skp2 (Yu et al., 1998) . Using Skp1 as a bait in a two-hybrid screen, we have cloned seven human Fbps, one of which is bTrcp (b-Transducin repeat containing protein), containing seven WD-40 domains (C Cenciarelli et al., in preparation) . This same protein has been also recently identi®ed as an interactor of the HIV-1 viral protein Vpu (Margottin et al., 1998) . b-Trcp is the human homolog of Xenopus b-TrCp (94% overall identity at the amino acid level; 96% similarity) (Spevak et al., 1993) , Drosophila Slimb (77% id, 87% si) (Jiang and Struhl, 1998) , C. elegans LIN-23 (57% id, 69% si) (Kipreos et al., 1999) , and probably of S. cerevisiñ Met30 (28% id, 45% si) (Mountain et al., 1993) . The function of b-TrCp homologs is intimately connected with cell proliferation. Indeed, Xenopus bTrCp and Drosophila Slimb are negative regulators of the Wnt/b-catenin signaling pathway (Jiang and Struhl, 1998; Marikawa and Elinson, 1998) . Deletion in the C. elegans lin-23 genes results in generalized hyperplasia (Kipreos et al., 1999) . Finally, Met30 controls the degradation of the G1 regulatory proteins (see above).
b-catenin is an important regulator involved in the control of cell adhesion (via its interaction with Ecadherin) as well as of growth and development (as a mediator of the Wingless-Wnt pathway) (reviewed in Miller and Moon, 1996 and Peifer, 1997) . In response to the activation of the Wingless-Wnt pathway, degradation of b-catenin decreases. Consequently, bcatenin accumulates and migrates into the nucleus where it binds to a transcription factor of the Lef-1/ Tcf-1 family to modulate the expression of target genes (Behrens et al., 1996; Molenaar et al., 1996) . Importantly, one of these genes was found to be proto-oncogene c-myc (He et al., 1998; Pennisi, 1998) . b-catenin also binds the product of the tumor suppressor gene, adenomatous polyposis coli (Apc) (Rubinfeld et al., 1993; Su et al., 1993) . Genetic mutations or altered protein expression of E-cadherin, b-catenin, and Apc have been implicated in human cancers, and all result in increased b-catenin levels which in turn leads to increased Lef-1/Tcf-1 transcriptional activity and deregulated proliferation (reviewed in Pennisi, 1998) .
Xenopus b-TrCp and Drosophila Slimb are negative regulators of the Wnt/b-catenin signaling pathway (Jiang and Struhl, 1998; Marikawa and Elinson, 1998) . Because b-Trcp is the human homolog of Xenopus b-TrCp and Drosophila Slimb, we asked whether human b-Trcp is a subunit of an SCF and, as such, regulates the stability of b-catenin.
Results

Human b-Trcp interacts with Cul1 and Skp1
It has been shown that human Skp1 and Cul1 proteins form an SCF with the Fbp Skp2. However, it is not known if the Skp1/Cul1 complex associates with several distinct Fbps as the homologous yeast complex does. To answer this question, we used a baculovirus expression system to produce in insect cells human Figure  1a , lanes 2 ± 3 and 8 ± 9). When cells were infected in the absence of Skp1, a very weak interaction between Cul1 and b-Trcp was observed (data not shown). This was due either to a direct weak binding between Cul1 and b-Trcp (which is also observed between Cul1 and Skp2 (Lisztwan et al., 1998; Lyapina et al., 1998)) or to the presence of insect Skp1. We also tested whether b-Trcp can interact with Cul2, which among the six human cullins is the most homologous to Figure  3a) . To determine whether this accumulation was due to an increase in b-catenin stability, we measured the half-life of b-catenin using pulse chase analysis. Human 293 cells were transfected with HA-tagged b-catenin alone or in combination with the wild type or mutant b-Trcp. While wild type b-Trcp had little eect on the degradation of b-catenin, the F-box deletion mutant prolonged the half life of b-catenin from 1 ± 4 h ( Figure  3b ).
Concluding remarks
Human b-Trcp is involved in CD4 degradation induced by the HIV-1 Vpu protein (Margottin et al., 1998) . In fact, it has been shown that Vpu recruits b- (Gonen et al., 1999) .
In vitro reconstitution experiments with puri®ed proteins will be necessary to formally prove that SCF b-Trcp directly ubiquitinates b-catenin and IkB-a. Deregulation of b-catenin proteolysis is associated with malignant transformation. Thus, the identi®cation of SCF b-Trcp as the enzyme that ubiquitinates b-catenin is expected to have a signi®cant impact on both cancer biology and clinical oncology. 
Materials and methods
Recombinant proteins
cDNA fragments encoding the following human proteins: Flag-tagged b-Trcp, Flag-tagged (DF)b-Trcp, HA-tagged Cul1, HA-tagged Cul2, Skp1, b-catenin, His-tagged cyclin D1, were inserted into the baculoviral expression vector pBacpak-8 (Clonetech) and cotransfected into the Sf9 cells with linearized baculovirus DNA using the BaculoGold transfection kit (Pharmingen). Recombinant viruses were used to infect 5B cells and assayed for expression of their encoded protein by immunoblotting as described (Hannon, 1995) .
Construction of F-box mutants
(DF)b-Trcp mutant was obtained by removing the ®rst 540 bp of the b-Trcp with the KpnI restriction enzyme, and replacing it with a PCR fragment containing nucleotides 1 ± 97. The ®nal construct encoded a protein lacking residues 30 ± 179.
Antibodies
Anti-Cul1 antibodies were generated by injecting rabbits and mice with the following amino acid peptide: (C)DGEKDTYSYLA. This peptide corresponds to the carboxy-terminus of human Cul1 and is not conserved in other cullins. Anti-Cul2 antibody was generated by injecting rabbits with the following amino acid peptide: (C)ESSFSLNMNFSSKRTKFKITTSMQ. This peptide is located 87 amino acids from the carboxy-terminus of human Cul2 and is not conserved in other cullins. The anti-Skp1 antibody was generated by injecting rabbits with the peptide (C)EEAQVRKENQW, corresponding to the carboxy-terminus of human Skp1. The cysteine residues (C) were added in order to couple the peptides to keyhole limpet hemocyanin (KLH). All of the antibodies were generated against peptides whose sequence showed high antigenic index (high hydrophilicity, good surface probability, good¯exibility, and good secondary structure). Rabbits and mice were injected with peptide-KLH mixed with complete Freund's adjuvant. Subsequently they were injected with the peptide in incomplete Freund's adjuvant, every 2 weeks, until a signi®cant immunoreactivity was detected by immunoprecipitation of 35 S-methionine labeled HeLa extract. These antisera recognized bands at the predicted size in both human extracts and a extracts containing recombinant proteins. Polyclonal antibodies to Cul1, Skp1 and Cul2, as well as mouse monoclonal antibodies (Mabs) to Cul1 were generated and characterized in collaboration with Zymed Inc.
Rat anti-HA antibody was from Boehringer Mannheim (cat. #1867423), rabbit anti-HA antibody was from Santa Cruz (cat. #sc-805), mouse anti-Flag antibody was from Kodak (cat. #IB13010), rabbit anti-Flag antibody was from Zymed (cat. #71-5400), anti-Skp1 and anti-b-catenin mouse antibodies were from Transduction Laboratories (cat. #C19220 and P46020, respectively). The preparation, puri®cation and characterization of a Mab to human cyclin D1 (clone AM29, cat. #33-2500) was performed in collaboration with Zymed Inc. Antiserum to human cyclin D1 was produced as described (Pagano et al., 1994) .
Transient transfections, immunoprecipitation, immunoblotting
cDNA fragments encoding the following human proteins: Flag-tagged b-Trcp, Flag-tagged (DF)b-Trcp, HA-tagged bcatenin, untagged b-catenin, Skp1, cyclin D1, were inserted into the mammalian expression vector pcDNA3 (Invitrogen).
Cells were transfectd wtih FuGENE transfection reagent (Boehringer, cat. #1-814-443) according to the manufacturer's instruction. Conditions for immunoprecipitation and immunoblotting have been previously described (Pagano et al., 1995) .
Cell culture and extract preparation
Human transformed primary embryonic kidney 293 T cells were obtained from the American Type Culture Collection, and then grown as previously described (Pagano et al., 1993) . Conditions for protein extraction have been previously described (Pagano et al., 1993) .
Note added in proof
Similarly to the conclusions reported herein, W Harper and colleagues also have found an involvement of b-Trcp in the degradation of b-catenin (WH, personal communication).
